Editor’s note: This is a developing news story. Please check back soon for updates. Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as ...

While liquid nitrogen cryotherapy is effective, easy, and quick to administer, its application can cause a considerable amount of discomfort. This pain is frequently biphasic, with an immediate ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...